WAUKESHA – On Wednesday, GE Healthcare introduced a new technology called MAVRIC SL that will aid medical professionals when working with patients who have had joint replacements and other implants.
MAVRIC SL is a magnetic resonance imaging technique designed to address the growing clinical need to more accurately image soft tissue and bone in patients with MR Conditional-labeled implants, such as joint replacements and other instrumentation, according to a company statement.

“The addition of MAVRIC SL to a standardized MR protocol is instrumental in providing accurate, reproducible diagnosis of adverse tissue reactions around implants,” said Dr. Hollis Potter, chief of MR Imaging at Hospital for Special Surgery in New York and a lead member of the development team. “Even in asymptomatic patients, the MAVRIC SL technology can recognize an issue that needs to be monitored, providing valuable clinical information for an issue that can have significant human and economic costs, particularly when diagnosis is delayed.”

The development of MAVRIC SL was a collaborative effort between GE, Hospital for Special Surgery and Stanford University.

“GE Healthcare is committed to Humanizing MR by focusing on the needs of the patient, technologist and clinician,” said Richard Hausmann, president and CEO of GE Healthcare’s Magnetic Resonance business unit. “Current MR technology is limited and MAVRIC SL addresses this major gap in patient care, as the number of procedures requiring MR technologies continues to grow.”